- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02475811
3D Ultrasonography Fetal Lung Volume Measurement and Neonatal Respiratory Function
The Role of 3D Ultrasonography Fetal Lung Volume Measurement in the Prediction of Neonatal Respiratory Function Outcome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
One hundred healthy women with singleton pregnancies presented in the 1st stage of labour will beincluded in the study. Participants will be divided into two groups; Group A (n: 50 - women pregnant ± 34-37 weeks gestation) & Group B (n: 50 - women pregnant ± 37+1-40 weeks gestation). Gestational age (GA) is established by menstrual dates then confirmed by obstetric ultrasound.
For both groups, full history will be taken including the receiving of antenatal steroids followed by general, abdominal & pelvic examination to confirm the stage of labour & to exclude the presence of rupture of membranes. Obstetric ultrasound will be done to confirm GA, assess amniotic fluid index (AFI) & to exclude fetal anomalies. Fetal lung volume (FLV) measured using Voluson 730 Expert ultrasonography machine (GE Healthcare Austria GmbH, Seoul, Korea) equipped with a 4- to 8- MHz transabdominal transducer for 3-dimensional (3D) volume scanning. A single examiner will perform all ultrasound examinations with the following technique; a transverse section of the fetal thorax at the level of the 4-chamber view, with the fetal heart proximal to the transducer, was identified by 2-dimensional ultrasonography, and the volume box will be adjusted to scan the entire fetal thorax. The maximum resolution will be adjusted. The angle of volume sampling varied throughout gestational age with a maximum limit of 75° in the third trimester. After scanning the volume, multiplanar imaging in the 3 orthogonal ultrasonographic sections will be analyzed to reconstruct the 3D ultrasound image. Before its volume was analyzed, each lung was carefully identified on the 3 orthogonal multiplanar imaging sections. The investigators will use the rotational technique that entails the VOCAL imaging program to measure lung volume. A transverse section of the multiplanar imaging will be chosen as the reference image for volume analyses (Figure 1). Right lung volume will be measured by a series of area tracing of the studied lung after serial rotations of 30° (6 times; Figures 2 and 3). Reviewing parallel slices executed through the whole lung in the 3 perpendicular planes allowed us to check the adequacy of our rotational area tracing approach. Right lung volume was automatically measured and plotted against gestational age, taking about 2 minutes to estimate the lung volume. After child birth, neonatal respiratory functions will be assessed using APGAR score at (1, 5 and 10 min) together with occurrence of RDS and the further need for neonatal ICU admission and respiratory support measurements.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 12151
- Kasr Alainy medical school
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- One hundred healthy women with singleton pregnancies presented in the 1st stage of labour were included in the study. Participants were divided into two groups; Group A (n: 50 - women pregnant ± 34-37 weeks gestation) & Group B (n: 50 - women pregnant ± 37+1-40 weeks gestation). Gestational age (GA) is established by menstrual dates then confirmed by obstetric ultrasound
Exclusion Criteria:
- Exclusion criteria include the maternal administration of respiratory depressants within 2 hours from the delivery of the fetus (e. g., opioid analgesic & general anesthesia upon doing CS) or oligohydramnios (amniotic fluid index < 5th centile), rupture of membranes, the presence of fetal malformations (chest, heart or abdominal) or abnormal fetal growth (defined as: estimated fetal weight < 5th centile or > 95th centile and/or abdominal circumference < 5th centile or > 95th centile). Also, women with a cardiac pacemaker were excluded (as the transmitter necessary for the lung volume measurements could disturb the function of the pacemaker).
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Apgar score
Time Frame: 1 minute after delivery
|
1 minute after delivery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Neonatal ICU admission
Time Frame: 24 hour after delivery
|
24 hour after delivery
|
Apgar score
Time Frame: 5 minutes after delivery
|
5 minutes after delivery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ahmed Maged, Kasr Alainy medical school
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 137
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neonatal Respiratory Function
-
University College, LondonMinistry of Health and Child Welfare, Zimbabwe; Biomedical Research and Training... and other collaboratorsRecruitingNeonatal Encephalopathy | Prematurity | Neonatal Seizure | Neonatal Jaundice | Neonatal Sepsis | Neonatal Death | Neonatal Respiratory Failure | Neonatal Hypoglycemia | Neonatal Disorder | Neonatal HypothermiaZimbabwe, Malawi
-
Centre Hospitalier Metropole SavoieCompletedRespiratory FunctionFrance
-
University Hospital, MontpellierAix Marseille Université; LBM- Nanosecurity platform - CEA Grenoble; LR2N - Nanosecurity...CompletedRespiratory Function
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)RecruitingRespiratory Complication | Respiratory Function LossUnited States
-
University Medical Center NijmegenOrion Corporation, Orion PharmaCompletedRespiratory Muscle FunctionNetherlands
-
Federal University of Mato GrossoCompletedRespiratory Function Tests
-
Mayo ClinicRecruitingRespiratory Complication | Respiratory Function LossUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownInadequate or Impaired Respiratory Function
-
Cliniques universitaires Saint-Luc- Université...CompletedSpirometry | Respiratory Function TestsBolivia
-
Yaron Har-ShaiUnknownBreast Reconstruction | Respiratory FunctionIsrael
Clinical Trials on 3D ultrasonography
-
Ain Shams UniversityCompletedRespiratory Distress Syndrome
-
Nanfang Hospital of Southern Medical UniversityZhujiang HospitalUnknown
-
University Hospital, UmeåRecruitingPerianal Abscess | Incontinence | Anal FistulasSweden
-
Ospedale Policlinico San MartinoActive, not recruitingEndometriosis, Rectum | Endometriosis of ColonItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis, Rectum | Endometriosis, SigmoidItaly
-
Benha UniversityUnknownPostmenopausal BleedingEgypt
-
Ankara City Hospital BilkentNot yet recruitingObstructive Sleep Apnea | Respiratory Complication | Airway Edema
-
Waldfriede HospitalRecruiting
-
Cantonal Hosptal, BasellandInsel Gruppe AG, University Hospital BernRecruitingObstructive Sleep Apnea | Sleep-Disordered BreathingSwitzerland